Department of Pharmacology, All India Institute of Medical Sciences, New Delhi, India.
Psychopharmacology (Berl). 2013 Dec;230(4):589-605. doi: 10.1007/s00213-013-3185-7. Epub 2013 Jul 6.
Clitoria ternatea, commonly known as Aparajita, is used as Medhya rasayana in Ayurveda. The role of C. ternatea in experimental models of cognitive impairment is yet to be explored.
The present study was designed to study the effect of aqueous and hydroalcoholic extracts of C. ternatea on biochemical and behavioral parameters related to cognitive impairment in in vitro and in vivo studies.
In vitro free radical scavenging and enzyme-inhibitory (cholinesterase, glycogen synthase kinase-3-β, rho kinase, prolyl endopeptidase, catechol-O-methyl transferase, and lipoxygenase) activities of aqueous and hydroalcoholic extracts of C. ternatea plant were evaluated. Based on in vitro results, hydroalcoholic extract of C. ternatea (100, 300, and 500 mg/kg, p.o.) was selected for evaluation in intracerebroventricularly injected streptozotocin (STZ)-induced cognitive impairment in male Wistar rats. Behavioral assessment was performed at baseline and on the 14th, 21st, and 28th days after STZ injection using elevated plus maze, passive avoidance, Morris water maze, and photoactometer. Oxidative stress parameters (malondialdehyde, reduced glutathione, nitric oxide levels, and superoxide dismutase activity), cholinesterase activity, and rho kinase (ROCK II) expression were studied in cerebral cortex and hippocampus of rats' brain at the end of the study.
The hydroalcoholic extract possessed significantly more in vitro antioxidant and enzyme-inhibitory activities as compared to aqueous extract. The hydroalcoholic extract of C. ternatea prevented STZ-induced cognitive impairment dose dependently by reducing oxidative stress, cholinesterase activity, and ROCK II expression.
In vitro and in vivo results suggest the potential of hydroalcoholic extract of C. ternatea for treatment of cognitive deficit in neurological disorders.
三叶鬼针草,俗称 Aparajita,在阿育吠陀中被用作 Medhya rasayana。三叶鬼针草在认知障碍的实验模型中的作用尚未被探索。
本研究旨在研究三叶鬼针草的水提物和水醇提物对体外和体内与认知障碍相关的生化和行为参数的影响。
评估三叶鬼针草植物的水提物和水醇提物的体外自由基清除和酶抑制(胆碱酯酶、糖原合酶激酶-3-β、rho 激酶、脯肽内切酶、儿茶酚-O-甲基转移酶和脂氧合酶)活性。基于体外结果,选择三叶鬼针草的水醇提物(100、300 和 500mg/kg,po)用于评价脑室注射链脲佐菌素(STZ)诱导的雄性 Wistar 大鼠认知障碍。在 STZ 注射后第 14、21 和 28 天进行行为评估,使用高架十字迷宫、被动回避、Morris 水迷宫和光测仪。在研究结束时研究大鼠大脑皮质和海马中的氧化应激参数(丙二醛、还原型谷胱甘肽、一氧化氮水平和超氧化物歧化酶活性)、胆碱酯酶活性和 rho 激酶(ROCK II)表达。
水醇提物比水提物具有更显著的体外抗氧化和酶抑制活性。水醇提物可剂量依赖性地预防 STZ 诱导的认知障碍,降低氧化应激、胆碱酯酶活性和 ROCK II 表达。
体外和体内结果表明,三叶鬼针草水醇提物具有治疗神经障碍认知缺陷的潜力。